Senior Vice President, Research & Development, ModMab Therapeutics, Inc.
BIOGRAPHY
FEB 27, 2019 3:00 PM PST
Share
Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates
Presented at:
Drug Discovery 2019
Speaker
Abstract
In today's presentation I will give an overview to developing NextGen ADCs. We will discuss everything from the beginning stages of development to the varying ADC combination therapies available. (There are currently 23 ADCs in total being studied in 45 combination trials with 10 different immune checkpoint modulators).
Learning Objectives:
1. This presentation will discuss past, present challenges associated with developing antibody-drug conjugates (ADCs), a novel modality of targeted cancer chemotherapy
2. Presentation will also highlight key factors that influence in developing next generation ADCs.
You May Also Like
MAY 11, 2021
10:00 AM PDT
C.E. CREDITS
MAY 11, 2021
10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021
7:00 AM PDT
C.E. CREDITS
SEP 14, 2021
7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021
7:00 AM PDT
C.E. CREDITS
JUN 09, 2021
7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021
8:00 AM PDT
C.E. CREDITS
JUL 15, 2021
8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
OCT 20, 2021
10:00 AM PDT
C.E. CREDITS
OCT 20, 2021
10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
OCT 12, 2021
9:00 AM PDT
C.E. CREDITS
OCT 12, 2021
9:00 AM PDT
Date: October 12, 2021 Time: 9:00am (PDT), 12:00pm (EDT) SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization o...
FEB 27, 2019 3:00 PM PST
Share
Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates
Presented at:
Drug Discovery 2019
Specialty
Immunology
Cancer Research
Biotechnology
Oncology
Cancer Diagnostics
Laboratory Testing
Protein
Clinical Diagnostics
Cancer Therapeutics
Drug Discovery
Antibodies
Gene Sequencing
Cell Biology
Cancer
Dna Sequencing
Geography
North America33%
Asia33%
Europe33%
Registration Source
Website Visitors100%
Job Title
Facility/Department Manager22%
Pharmacist11%
Student11%
Clinical Laboratory Scientist11%
Medical Doctor/Specialist11%
Educator/Faculty11%
Medical Laboratory Technician11%
Scientist11%
Organization
Academic Institution33%
Contract Research Organization (Cro)33%
Hospital22%
Manufacturer - Other11%
Loading Comments...
Finish Registering
-
NOV 03, 2021Opioid Crisis 2021 -
NOV 09, 2021IonWorld 2021
-
NOV 10, 2021Clinical Diagnostics & Research 2021
-
DEC 01, 2021Sample to Answer Clinical Series
-
JAN 25, 2022Lab Compliance Connect
- See More
-
OCT 27, 2021
-
OCT 27, 2021
- See More
